3533 POSTER Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in 1st line metastatic pancreatic cancer–amulticenter phase II study
Cited by 14
Abstract
Related Papers
No related papers found
Powered by citation graph analysis
No related papers found
Powered by citation graph analysis